❌

Normal view

Received — 22 October 2025 ⏭ Favourites

Oncogene - Issue - nature.com science feeds
Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma Nobutoshi Esaki · Tomoka Sakoda · Ryota Ando · Yuki Miyai · Tadashi Iida · Yasuyuki Mizutani · Mirai Yoshida · Yuki Hara · Makoto Matsuyama · Tomoe Kobayashi · Yukihiro Shiraki · Shinji Mii · Jiro Ichikawa · Tomonori Kawasaki · Shino Manabe · Tomohisa Sakai · Yoshihiro Nishida · Masahide Takahashi · Atsushi Enomoto
Oncogene, Published online: 21 October 2025; doi:10.1038/s41388-025-03605-8Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma
21 October 2025 at 08:00

Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma

Oncogene - Issue - nature.com science feeds

By: Nobutoshi Esaki · Tomoka Sakoda · Ryota Ando · Yuki Miyai · Tadashi Iida · Yasuyuki Mizutani · Mirai Yoshida · Yuki Hara · Makoto Matsuyama · Tomoe Kobayashi · Yukihiro Shiraki · Shinji Mii · Jiro Ichikawa · Tomonori Kawasaki · Shino Manabe · Tomohisa Sakai · Yoshihiro Nishida · Masahide Takahashi · Atsushi Enomoto

21 October 2025 at 08:00

Oncogene, Published online: 21 October 2025; doi:10.1038/s41388-025-03605-8

Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma